Dr Colin Dourish

Colin T Dourish PhD DSc is a Director, Co-Owner and one of the two founders of Blue Day Healthcare. Dr Dourish has a successful track record in CNS drug discovery and drug development in both major pharmaceutical and biotechnology companies. Prior to co-founding Blue Day Healthcare, he was one of the two founders and owners of P1vital and its affiliate company P1vital Products. Prior to co-founding P1vital and P1vital Products, he was Senior Vice President Research and CSO of Vernalis Group plc, Research Director and co-founder of Cerebrus Limited, Director of Neuropharmacology at Wyeth Research and Section Head at Merck. Dr Dourish has over 450 publications in scientific and medical journals and has edited four books in the areas of Psychopharmacology, Neuroscience, Neurology and Psychiatry. He is an Expert in Residence in the Medical Sciences Division of the University of Oxford. Dr Dourish received his BSc in Psychology and his PhD and DSc in Psychopharmacology from the Queen's University of Belfast and carried out postdoctoral research at the Department of Psychiatry, University of Saskatchewan in Canada and at the UCL Queen Square Institute of Neurology in London.